Fresh analysis suggests that patients who come off new GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who end conventional lifestyle plans.
Research printed in a major medical journal shows that while obese individuals frequently drop substantial amounts of their total mass while using the jabs, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.
"Individuals using these drugs should be informed of the danger of rapid weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.
Such speed of regain suggests a return to starting mass in about 18 months.
Comparing Treatments
The analysis, which reviewed 37 of studies involving over 9,000 of patients, compared the results of these new drugs with other pills.
Researchers emphasize that individuals who shed pounds through diet and exercise usually see a more gradual creep back—perhaps 0.1 kg a month—after stopping.
The Reason for the Rapid Regain
Doctors suggest the way of the drugs is key to understanding the accelerated rebound.
These medications imitate a body's own chemical called GLP-1, which helps regulate hunger.
"Artificially providing GLP-1 levels several times higher than the body's typical production may cause the system to produce less of its endogenous hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication leads to appetite is unsuppressed, making overeating far more likely."
A Chronic Condition?
Medical guidelines advise the jabs for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
Many experts contend that, considering the likelihood of relapse, the treatment should be considered ongoing.
This perspective is supported by drug manufacturers, who note that the findings "highlight the persistent nature of obesity," akin to managing diseases like hypertension.
User Testimonies
Users who have come off the jabs explain a intense resurgence of hunger.
"It was like a switch activating and I was suddenly starving," said an individual.
The struggle is worsened if individuals have not adopted lasting lifestyle or habit modifications during treatment.
Significant Use
Recent estimates indicate that a significant number of people in the UK have tried these injections in the past year, with desire being substantial.
- Adoption is higher among women than males.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
In conclusion, experts stress that while the jabs are powerful tools for shedding pounds, they are not a standalone cure and maintained weight loss likely depends on integrated lifestyle changes.
